D R Lara
Overview
Explore the profile of D R Lara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Araujo R, Lara D
Eur Psychiatry
. 2016 Jul;
37:14-21.
PMID: 27442978
Background: All types of abuse and neglect have been associated with suicide attempts. However, the association between the level of each type of childhood trauma and suicidal behavior severity (including...
2.
Schmidt A, Rodrigues R, Pipa C, Brandalise L, Lorenzi T, Lara D
J Affect Disord
. 2010 May;
126(1-2):49-54.
PMID: 20434780
Background: Preliminary data has shown temperament differences in workers of a few professions, particularly in artists. Methods: 3805 subjects (75.5% female, mean 32.4+/-9.8 years) of 23 broad professional areas answered...
3.
Lorenzi T, Borba D, Dutra G, Lara D
J Affect Disord
. 2009 Jun;
121(1-2):161-4.
PMID: 19524303
Background: Temperament relates to emotions and the prevailing mood or affective temperament. Uric acid (UA) is the end-product of purine metabolism and has been associated with psychological features such as...
4.
5.
Schmidt A, Bohmer A, Antunes C, Schallenberger C, Porciuncula L, Elisabetsky E, et al.
Br J Pharmacol
. 2009 Jan;
156(1):163-72.
PMID: 19133997
Background And Purpose: Allopurinol is a potent inhibitor of the enzyme xanthine oxidase, used primarily in the treatment of hyperuricemia and gout. It is well known that purines exert multiple...
6.
Brunstein M, Silveira Jr E, Chaves L, Machado H, Schenkel O, Belmonte-de-Abreu P, et al.
Neurosci Lett
. 2007 Feb;
414(1):61-4.
PMID: 17289263
Adenosine is an important modulator of the nervous system that has been implicated in the pathophysiology of schizophrenia. We studied peripheral adenosine metabolism by determining the activity of serum adenosine...
7.
de Oliveira R, DallIgna O, Tort A, Schuh J, Neto P, Santos Gomes M, et al.
Behav Pharmacol
. 2005 Mar;
16(2):79-84.
PMID: 15767842
N-Methyl-D-aspartate (NMDA) receptor antagonists cause hyperlocomotion and cognitive deficits in rodents, and caffeine-tolerant mice show diminished locomotor response to NMDA receptor antagonists. The aim of this study was to evaluate...
8.
Machado-Vieira R, Lara D, Souza D, Kapczinski F
Med Hypotheses
. 2002 May;
58(4):297-304.
PMID: 12027524
The purinergic system, which includes the anticonvulsant and antikindling neuromodulator adenosine and the neurotransmitter ATP, modulates second messenger systems, neurotransmitters, energy metabolism and different behaviors, such as sleep, motor activity,...
9.
Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study
Machado-Vieira R, Lara D, Portela L, Goncalves C, Soares J, Kapczinski F, et al.
Eur Neuropsychopharmacol
. 2002 May;
12(3):269-72.
PMID: 12007679
S100B protein is a calcium-binding protein mostly derived from glial cells, which exerts trophic or toxic effects on neural cells depending on its concentration. Since serum S100B levels has been...
10.